Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00780455
What this trial is testing

Rehabilitation Study in MS Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer 4
Testing effectiveness (Phase 2)Study completedNCT01772199
What this trial is testing

Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 131
Not applicableStudy completedNCT00594087
What this trial is testing

Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)

Who this might be right for
Relapsing Remitting Multiple SclerosisSleep Initiation and Maintenance DisordersFatigue
University of Vermont 30
Large-scale testing (Phase 3)Study completedNCT03774407
What this trial is testing

Vaginal Estriol in Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic Bladder
Texas Tech University Health Sciences Center 21
Large-scale testing (Phase 3)Study completedNCT01707992
What this trial is testing

The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 2,199
Large-scale testing (Phase 3)Ended earlyNCT03870763
What this trial is testing

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 11
Not applicableStudy completedNCT04705610
What this trial is testing

Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis (MS) Relapsing RemittingMultiple Sclerosis (MS) Primary Progressive+4 more
Association de Recherche Bibliographique pour les Neurosciences 76
Early research (Phase 1)Active Not RecruitingNCT05755061
What this trial is testing

WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multiple Sclerosis

Who this might be right for
Multiple SclerosisRelapsing-remitting Multiple Sclerosis
Kessler Foundation 31
Early research (Phase 1)Study completedNCT04602390
What this trial is testing

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)Relapsing Remitting Multiple Sclerosis
Anokion SA 34
Not applicableEnded earlyNCT01790269
What this trial is testing

Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Charite University, Berlin, Germany 21
Not applicableStudy completedNCT01626248
What this trial is testing

Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control

Who this might be right for
Multiple Sclerosis
John F. Foley, MD 164
Large-scale testing (Phase 3)Study completedNCT00803049
What this trial is testing

Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 742
Testing effectiveness (Phase 2)Ended earlyNCT02222948
What this trial is testing

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Genzyme, a Sanofi Company 112
Not applicableStudy completedNCT02677077
What this trial is testing

Clinical Disease Activity With Long Term Natalizumab Treatment

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 277
Large-scale testing (Phase 3)Study completedNCT00200655
What this trial is testing

Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Nantes University Hospital 40
Not applicableUnknownNCT04073940
What this trial is testing

Exploration of Brain Changes Due to a Targeted Ballet Program in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of Illinois at Urbana-Champaign 30
Post-approval studies (Phase 4)Study completedNCT00267319
What this trial is testing

FOCUS Fatigue Outcome in Copaxone USers

Who this might be right for
Multiple Sclerosis
Sanofi 111
Not applicableStudy completedNCT07233902
What this trial is testing

MS Synchronous vs Asynchronous Exercise Study

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting
Yeditepe University 16
Not applicableStudy completedNCT05604092
What this trial is testing

Lesion Load and Location in Relation to Cognition, Fatigue and Physical Disability in RRMS

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Assiut University 63
Post-approval studies (Phase 4)Study completedNCT01085318
What this trial is testing

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

Who this might be right for
Multiple Sclerosis
EMD Serono 38
Next Page